Business we founded
Earlybird Health II Fund
The Earlybird Health Fund II secured 175M€ in 2023. The fund focuses on early and later stage opportunities in digital health, medical devices, diagnostics, enabling technologies and biopharma across Europe.
Amyl Therapeutics
Founded in 2021 in Leuven, Belgium, Amyl Therapeutics is a A preclinical-stage biotechnology company pioneering a breakthrough approach to treat rare and severe peripheral protein misfolding diseases and neurodegenerative diseases.
Priothera
Founded in 2020, Priothera is a Dublin based biotech, dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
Handl Therapeutics
Founded in 2019, Handl Therapeutics is based in Leuven, Belgium, and aims to use the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases to start addressing significant unmet medical needs in healthcare. The company has been acquired by UCB Pharma in 2020.
Captor Therapeutics
Captor Therapeutics is a Polish-Swiss biopharmaceutical company leveraging Targeted Protein Degradation (TPD) technology to discover and develop breakthrough therapeutics for high unmet medical needs. Florent Gros served as a director of the Polish company until 2024, after the company went public on the Polish stock exchange.
Earlybird Growth Fund
Earlybird Growth Opportunities V is a venture capital fund managed by Earlybird Venture Capital. The fund invests in retail tech including food tech, fin- & insurtech and Industrial & mobility tech including logtech, and mobility, supply chain, internet of things / connected devices, artificial intellugence / data analytics, crypto / blockchain, robotics and virtual reality, and health.
Tavira Therapeutics
Founded in 2023, the company is transforming gene therapy with an advanced AAV delivery platform, enhancing viral specificity and accelerating development through modular, post-manufacture enzymatic AAV vector modification.
Pharmakina
Pharmakina is a Congo-base pharmaceutical and health products company focused on improving access to essential medicines and healthcare solutions across Central and East Africa. Originally known for the cultivation and extraction of quinine from cinchona plantations, the company has expanded into the manufacturing and distribution of pharmaceutical products, nutraceuticals, and consumer health solutions. Pharmakina plays a key role in regional healthcare by supporting malaria treatment initiatives, local pharmaceutical production, and economical development throughout the region.
2400 Sourires
2400 Sourires is a humanitarian NGO dedicated to improving children’s oral health and access to dental care in underserved communities, particularly in Africa. The organization conducts dental missions, prevention campaigns, and oral health education programs while supporting local healthcare professionals through training and capacity building. Through partnerships with schools, clinics, and volunteers, 2400 Sourires works to promote long-term oral health awareness and ensure that vulnerable children can grow up with healthier smiles and improved well-being.
NGOs we support
2400 sourires
Their mission is to welcome every child weakened by poverty and violence in a secure environment with care, food and education.